Dissecting the interaction between COVID-19 and diabetes mellitus.
J Diabetes Investig
; 11(5): 1104-1114, 2020 Sep.
Article
in English
| MEDLINE | ID: covidwho-724172
ABSTRACT
Coronavirus disease 2019 (COVID-19) is a global pandemic that is caused by a novel coronavirus, severe acute respiratory syndrome coronavirus-2. Data from several countries have shown higher morbidity and mortality among individuals with chronic metabolic diseases, such as diabetes mellitus. In this review, we explore the contributing factors for poorer prognosis in these individuals. As a significant proportion of patients with COVID-19 also have diabetes mellitus, this adds another layer of complexity to their management. We explore potential interactions between antidiabetic medications and renin-angiotensin-aldosterone system inhibitors with COVID-19. Suggested recommendations for the use of antidiabetic medications for COVID-19 patients with diabetes mellitus are provided. We also review pertinent clinical considerations in the management of diabetic ketoacidosis in COVID-19 patients. In addition, we aim to increase clinicians' awareness of the metabolic effects of promising drug therapies for COVID-19. Finally, we highlight the importance of timely vaccinations for patients with diabetes mellitus.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Diabetes Complications
/
Diabetes Mellitus
/
COVID-19
/
Obesity
Type of study:
Prognostic study
Topics:
Long Covid
/
Vaccines
Language:
English
Journal:
J Diabetes Investig
Year:
2020
Document Type:
Article
Affiliation country:
Jdi.13326
Similar
MEDLINE
...
LILACS
LIS